Drugs / plasmid DNA encoding for the VEGF165 gene
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00134433 | Nov 2004 → Mar 2007 | coronary artery disorder | Ottawa Heart Institute Research Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plasmid DNA encoding for the VEGF165 gene | “The angiogenesis treatment consists either of the injection of 2 mg (divided in 10 injections of 200 μg each) of plasmid DNA encoding for the VEGF165 gene or of 10 x 1 ml...” NCT00134433 ↗ |